Steffel Jan, Akhmedov Alexander, Greutert Helen, Lüscher Thomas F, Tanner Felix C
Cardiovascular Research, Physiology Institute, University of Zurich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
Circulation. 2005 Jul 19;112(3):341-9. doi: 10.1161/CIRCULATIONAHA.105.553735. Epub 2005 Jul 11.
Histamine can induce coronary vasospasm, leading to variant angina and acute myocardial infarction. However, the role of histamine in thrombus formation is ill defined. Hence, this study investigates whether histamine induces tissue factor (TF) expression in vascular cells.
Histamine (10(-8) to 10(-5) mol/L) induced TF expression in a concentration-dependent manner in human aortic endothelial and vascular smooth muscle cells, whereas TF pathway inhibitor expression remained unaffected. RT-PCR and Northern blotting revealed that histamine stimulated TF mRNA transcription, peaking at 1 hour. Protein expression increased 18-fold (P<0.02) with a maximum at 5 hours, which was paralleled by a 4-fold augmentation in surface activity (P<0.01). These effects were completely prevented by pretreatment with the H1 receptor antagonists mepyramine (P<0.0001), chlorpheniramine, and diphenhydramine but not the H2 receptor antagonist cimetidine (P=NS). Histamine induced a time-dependent, H1 receptor-mediated activation of p38 MAP kinase (p38), p44/42 MAP kinase (ERK), and c-jun terminal NH2 kinase (JNK). Blocking of p38, ERK, or JNK with SB203580 (P<0.0001), PD98059 (P<0.0001), or SP600125 (P<0.0001), respectively, impaired histamine-induced TF expression in a concentration-dependent manner. In contrast, histamine-stimulated TF expression was increased by phosphatidylinositol 3-kinase inhibition with LY294002 or wortmannin, whereas it was not affected by Rho-kinase inhibition with Y-27632 or hydroxyfasudil.
Histamine induces expression of TF, but not TF pathway inhibitor, in vascular cells via activation of the H1, but not H2, receptor. This effect is mediated by the MAP kinases p38, ERK, and JNK. This observation may open novel perspectives in the treatment of variant angina and acute coronary syndromes.
组胺可诱发冠状动脉痉挛,导致变异型心绞痛和急性心肌梗死。然而,组胺在血栓形成中的作用尚不明确。因此,本研究探讨组胺是否诱导血管细胞中组织因子(TF)的表达。
组胺(10⁻⁸至10⁻⁵mol/L)在人主动脉内皮细胞和血管平滑肌细胞中以浓度依赖的方式诱导TF表达,而TF途径抑制剂的表达未受影响。逆转录聚合酶链反应(RT-PCR)和Northern印迹分析显示,组胺刺激TF信使核糖核酸(mRNA)转录,在1小时达到峰值。蛋白质表达增加18倍(P<0.02),在5小时达到最大值,同时表面活性增加4倍(P<0.01)。用H1受体拮抗剂美吡拉敏(P<0.0001)、氯苯那敏和苯海拉明预处理可完全阻止这些效应,但H2受体拮抗剂西咪替丁则不能(P=无显著性差异)。组胺诱导p38丝裂原活化蛋白激酶(p38)、p44/42丝裂原活化蛋白激酶(ERK)和c-jun末端氨基激酶(JNK)的时间依赖性、H1受体介导的活化。分别用SB203580(P<0.0001)、PD98059(P<0.0001)或SP600125(P<obx="0.0001)阻断p38、ERK或JNK,以浓度依赖的方式损害组胺诱导的TF表达。相反,用LY294002或渥曼青霉素抑制磷脂酰肌醇3激酶可增加组胺刺激的TF表达,而用Y-27632或羟基法舒地尔抑制Rho激酶则对其无影响。"
组胺通过激活H1受体而非H2受体诱导血管细胞中TF的表达,但不诱导TF途径抑制剂的表达。这种效应由丝裂原活化蛋白激酶p38、ERK和JNK介导。这一观察结果可能为变异型心绞痛和急性冠状动脉综合征的治疗开辟新的前景。